{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:54:00Z","timestamp":1761929640945},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T00:00:00Z","timestamp":1357516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T00:00:00Z","timestamp":1357516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep01008","type":"journal-article","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T10:07:28Z","timestamp":1357553248000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Anti-folate combination therapies and their effect on the development of drug resistance in Plasmodium vivax"],"prefix":"10.1038","volume":"3","author":[{"given":"Shuai","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"McCutchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,7]]},"reference":[{"key":"BFsrep01008_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4269\/ajtmh.2008.78.462","volume":"78","author":"K Rungsihirunrat","year":"2008","unstructured":"Rungsihirunrat, K., Sibley, C. H., Mungthin, M. & Na-Bangchang, K. Geographical distribution of amino acid mutations in Plasmodium vivax Dhfr and DHPS from malaria endemic areas of Thailand. Am J Trop Med Hyg 78, 462\u2013467 (2008).","journal-title":"Am J Trop Med Hyg"},{"key":"BFsrep01008_CR2","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1128\/AAC.49.10.4393-4395.2005","volume":"49","author":"M Imwong","year":"2005","unstructured":"Imwong, M. et al. Limited Polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand. Antimicrob Agents Chemother 49, 4393\u20134395 (2005).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep01008_CR3","unstructured":"A Strategic Framework for Malaria Prevention and Control during Pregnancy in the Africa Region. (World Health Organization Regional Office for Africa, 2004)."},{"key":"BFsrep01008_CR4","unstructured":"Intermittent preventive treatment for infants using sulfadoxine- pyrimethamine (SP-IPTi) for malaria control in Africa: implementation field guide. (WHO Global Malaria Programme (GMP) and Department of Immunization, Vaccines & Biologicals (IVB) and UNICEF, 2011)."},{"key":"BFsrep01008_CR5","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S1471-4922(01)02085-2","volume":"17","author":"CH Sibley","year":"2001","unstructured":"Sibley, C. H. et al. Pyrimethamine\u2013sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol 17, 582\u201388 (2001).","journal-title":"Trends Parasitol"},{"key":"BFsrep01008_CR6","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","volume":"85","author":"DS Peterson","year":"1988","unstructured":"Peterson, D. S., Walliker, D. & Wellems, T. E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Nat Acad Sci USA 85, 9114\u20139118 (1988).","journal-title":"Proc Nat Acad Sci USA"},{"key":"BFsrep01008_CR7","doi-asserted-by":"publisher","first-page":"13046","DOI":"10.1073\/pnas.0501747102","volume":"102","author":"P Kongsaeree","year":"2005","unstructured":"Kongsaeree, P. et al. Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance. Proc Natl Acad Sci USA 102, 13046\u201313051 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep01008_CR8","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1093\/emboj\/17.14.3807","volume":"17","author":"T Triglia","year":"1998","unstructured":"Triglia, T., Wang, P., Sims, P. F. & Hyde, J. E. Cowman AF Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J 17, 3807\u201315(1998).","journal-title":"EMBO J"},{"key":"BFsrep01008_CR9","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1128\/AAC.48.6.2214-2222.2004","volume":"48","author":"M Korsinczky","year":"2004","unstructured":"Korsinczky, M. et al. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. Antimicrob Agents Chemother 48, 2214\u201322 (2004).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep01008_CR10","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1128\/AAC.47.5.1514-1521.2003","volume":"47","author":"M Imwong","year":"2003","unstructured":"Imwong, M. et al. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob Agents Chemother 47, 1514\u20131521 (2003).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep01008_CR11","doi-asserted-by":"publisher","first-page":"13137","DOI":"10.1073\/pnas.182295999","volume":"99","author":"MD Hastings","year":"2002","unstructured":"Hastings, M. D. & Sibley, C. H. Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax. Proc Natl Acad Sci USA 99, 13137\u201313141 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep01008_CR12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1086\/381397","volume":"189","author":"MD Hastings","year":"2004","unstructured":"Hastings, M. D. et al. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. J Infect Dis 189, 744\u2013750 (2004).","journal-title":"J Infect Dis"},{"key":"BFsrep01008_CR13","doi-asserted-by":"publisher","first-page":"e4569","DOI":"10.1371\/journal.pone.0004569","volume":"4","author":"S Gesase","year":"2009","unstructured":"Gesase, S. et al. High Resistance of Plasmodium falciparum to Sulphadoxine\/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581. PLoS ONE 4(2), e4569 (2009).","journal-title":"PLoS ONE"},{"key":"BFsrep01008_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1368-7646(98)80208-2","volume":"1","author":"NJ White","year":"1998","unstructured":"White, N. J. Preventing antimalarial drug resistance through combinations. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 1, 3\u20139 (1998).","journal-title":"Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"BFsrep01008_CR15","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1098\/rspb.2010.1907","volume":"278","author":"T Antao","year":"2011","unstructured":"Antao, T. & Hastings, I. M. Environmental, pharmacological and genetic influences on the spread of drug-resistant malaria. Proc Biol Sci 278, 1705\u20131712 (2011).","journal-title":"Proc Biol Sci"},{"key":"BFsrep01008_CR16","first-page":"174","volume":"4","author":"HL Yang","year":"1999","unstructured":"Yang, H. L. Retrospect and Prospect of Application of antimalarial drugs in Yunnan province. J Practical Parasitic Dis 7 4, 174\u201376 (1999).","journal-title":"J Practical Parasitic Dis 7"},{"key":"BFsrep01008_CR17","unstructured":"Hainan Institute of Parasitic Diseases. The Study on the prevention of malaria in Hainan Island (1950\u20131983). (ed Hainan Institute of Parasitic Diseases, Hainan,1985)."},{"key":"BFsrep01008_CR18","first-page":"189","volume":"18","author":"LY Shang","year":"2000","unstructured":"Shang, L. Y., Xue, C. Q. & Su, S. Z. Evaluation of the effect of 40 years' anti-malaria measures in Henan Province. Chin J Parasitol Parasit Dis 18, 189\u2013190 (2000).","journal-title":"Chin J Parasitol Parasit Dis"},{"key":"BFsrep01008_CR19","first-page":"321","volume":"22","author":"BL Xu","year":"2011","unstructured":"Xu, B. L. et al. Malaria Evaluation on the Control Effect in Henan Province during 1970\u20132010. Henan J Prev Med 22, 321\u201326 (2011).","journal-title":"Henan J Prev Med"},{"key":"BFsrep01008_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4269\/ajtmh.2010.10-0004","volume":"83","author":"F Lu","year":"2010","unstructured":"Lu, F. et al. Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries. Am J Trop Med Hyg 83, 474\u2013479 (2010).","journal-title":"Am J Trop Med Hyg"},{"key":"BFsrep01008_CR21","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(03)12951-0","volume":"361","author":"C Roper","year":"2003","unstructured":"Roper, C. et al. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 361, 1174\u20131181 (2003).","journal-title":"Lancet"},{"key":"BFsrep01008_CR22","doi-asserted-by":"publisher","first-page":"e1000055","DOI":"10.1371\/journal.pmed.1000055","volume":"6","author":"RJ Pearce","year":"2009","unstructured":"Pearce, R. J. et al. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med 6, e1000055 (2009).","journal-title":"PLoS Med"},{"key":"BFsrep01008_CR23","first-page":"594","volume":"12","author":"JC Garza","year":"1995","unstructured":"Garza, J. C., Slatkin, M. & Freimer, N. B. Microsatellite allele frequencies in humans and chimpanzees, with implications for constraints on allele size. Mol Biol Evol 12, 594\u2013603 (1995).","journal-title":"Mol Biol Evol"},{"key":"BFsrep01008_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.mib.2006.07.002","volume":"9","author":"DI Andersson","year":"2006","unstructured":"Andersson, D. I. The biological cost of mutational antibiotic resistance: any practical conclusions? Current Opinion in Microbiology 9, 461\u2013465 (2006).","journal-title":"Current Opinion in Microbiology"},{"key":"BFsrep01008_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(09)70105-7","volume":"9","author":"PlJ Johnsen","year":"2009","unstructured":"Johnsen, P. l. J. et al. Factors affecting the reversal of antimicrobial-drug resistance. Lancet Infect Dis 9, 357\u2013364 (2009).","journal-title":"Lancet Infect Dis"},{"key":"BFsrep01008_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrmicro2319","volume":"8","author":"DI Andersson","year":"2010","unstructured":"Andersson, D. I. & Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 8, 260\u201371 (2010).","journal-title":"Nat Rev Microbiol."},{"key":"BFsrep01008_CR27","unstructured":"Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults. Recommendations for a public health approach. (World Health Organization, Geneva, 2006)."},{"key":"BFsrep01008_CR28","unstructured":"Co-trimoxazole prophylaxis for HIV-exposed and HIV-infected Infants and Children: Practical Approaches to Implementation and Scale-Up. (World Health Organization, Geneva, 2009)."},{"key":"BFsrep01008_CR29","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1128\/AAC.48.11.4301-4305.2004","volume":"48","author":"A Nahimana","year":"2004","unstructured":"Nahimana, A., Rabodonirina, M., Bille, J., Francioli, P. & Hauser, P. M. Mutations of Pneumocystis jirovecii Dihydrofolate Reductase Associated with Failure of Prophylaxis. Antimicrob Agents Chemother 48, 4301\u20135 (2004).","journal-title":"Antimicrob Agents Chemother"},{"key":"BFsrep01008_CR30","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1086\/315148","volume":"180","author":"L Ma","year":"1999","unstructured":"Ma, L., Borio, L., Masur, H. & Kovacs, J. A. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J Infect Dis 180, 1969\u20131978 (1999).","journal-title":"J Infect Dis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep01008","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep01008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep01008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:57:06Z","timestamp":1672984626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep01008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFsrep01008"],"URL":"https:\/\/doi.org\/10.1038\/srep01008","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,7]]},"assertion":[{"value":"24 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1008"}}